Overcoming impediments to global implementation of early antiretroviral therapy

New England Journal of Medicine

Volumn 373, Issue 9, 2015, Pages 875-876

  Karim, Salim S Abdool ^a,b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASYMPTOMATIC INFECTION; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; DRUG EFFICACY; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE COST; HEPATITIS B; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MEDICATION COMPLIANCE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK REDUCTION; SEXUAL TRANSMISSION; SOCIAL DISCRIMINATION; SOCIAL STIGMA; TIME TO TREATMENT; TUBERCULOSIS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; ISONIAZID; MALE; TUBERCULOSIS;

EID: 84940528274     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1508527     Document Type: Editorial

References (10)

1. Ho DD. Time to hit HIV, early and hard. N Engl J Med 1995; 333:450-1.
2. The TEMPRANO ANRS 12136 Study Group. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med 2015; 373:808-22.
3. The INSIGHT START Study Group. Initiation of antiretrovi-ral therapy in early asymptomatic HIV infection. N Engl J Med 2015;373:795-807.
4. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360: 1815-26.
5. Sterne JA, May M, Costagliola D, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009; 373:1352-63.
6. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
7. Celum C, Morrow RA, Donnell D, et al. Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial. Ann Intern Med 2014; 161: 11-9.
8. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization, 2015 (http://apps.who.int/iris/bitstream/10665/154590/1/9789241549059-eng.pdf?ua=1&ua=1).
9. Piot P, Abdool Karim SS, Hecht R, et al. Defeating AIDS-advancing global health. Lancet 2015; 386: 171-218.
10. Abdool Karim SS. Stigma impedes AIDS prevention. Nature 2011;474:29-31.